MétaCan
Menu
Back to cohort
Record W4411486897 · doi:10.1111/liv.70175

Hepatitis B Virus Variants and Cytokine Patterns in Acute Liver Failure and Transplant‐Free Survival

2025· article· en· W4411486897 on OpenAlexafffund
Nishi Patel, Annie Y. Chen, Carla Osiowy, Valerie Durkalski Mauldin, William M. Lee, Carla S. Coffin, Constantine Karvellas

Bibliographic record

VenueLiver International · 2025
Typearticle
Languageen
FieldMedicine
TopicHepatitis B Virus Studies
Canadian institutionsPublic Health Agency of CanadaUniversity of AlbertaUniversity of Calgary
FundersBaylor University Medical CenterCumming School of Medicine, University of CalgaryUniversity of AlbertaUniversity of California, San DiegoUniversity of OregonUniversity of PittsburghUniversity of California, Los AngelesUniversity of South CarolinaNational Institute of Diabetes and Digestive and Kidney DiseasesBaylor UniversityYale UniversityVirginia Commonwealth UniversityNorthwestern UniversityNational Institutes of HealthOhio State UniversityCanadian Institutes of Health ResearchUniversity of WashingtonEmory UniversityUniversity of PennsylvaniaMassachusetts General Hospital
KeywordsMedicineInternal medicineLiver transplantationGastroenterologyHepatitis B virusViremiaHepatitis BImmunologyTransplantationVirus

Abstract

fetched live from OpenAlex

ABSTRACT Background & Aims Only 25% of hepatitis B‐related acute liver failure (HBV‐ALF) patients survive without liver transplantation (transplant‐free survival, TFS). There is limited study of immunological and virological profiles in these patients. We analysed the association between hepatitis B viremia and cytokine patterns on TFS of HBV‐ALF patients. Methods We identified 48 acute and 20 history of HBV infection ALF patients from the US ALF Study Group registry (> 3400 patients). The inclusion criteria were age > 18 years, diagnosis of HBV‐ALF with hepatic encephalopathy and INR ≥ 1.5. Data were collected from ICU admission through day 21. Serum collected at admission and at days 3–5 were used for cytokine quantification by Luminex and novel HBV biomarkers, genotypes and variants. Results In 48 acute (50% F, median age 40 years) and 20 history/reactivation (40% F, median age 53 years) HBV‐ALF patients, there were 26 (54%) and 5 (25%) TFS, respectively. Detectable HBV DNA by clinical PCR assay (median 3.39 log 10 IU/mL, aOR 5.308; 95% CI: 1.217–23.155, p = 0.026) and qAHBc levels (median 4.5 log 10 IU/mL, aOR 4.466, 95% CI: 0.968–20.608, p = 0.050) were associated with TFS in acute HBV‐ALF patients. HBV variants associated with anti‐viral immune escape were more frequently detected in acute HBV‐ALF TFS patients compared to non‐TFS ( p < 0.05). TFS with acute HBV‐ALF had higher angiogenic factors (PDGF‐AA, p = 0.008; PDGF‐BB, p = 0.0006; VEGF‐A, p = 0.014) and lower pro‐inflammatory cytokine levels (IL‐1α, p = 0.031; IL‐2, p = 0.014; IL‐6, p = 0.039). Significant differences in HBV viremia were not observed in history/reactivation of HBV‐ALF patients. Conclusions Acute HBV‐ALF patients with TFS were often viremic with immune escape variants, increased angiogenic factors and decreased pro‐inflammatory cytokines. Trial Registration: ClinicalTrials.gov identifier: NCT00518440

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.002
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.002
Threshold uncertainty score0.007

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.002
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.013
GPT teacher head0.260
Teacher spread0.247 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations9
Published2025
Admission routes2
Has abstractyes

Explore more

Same venueLiver InternationalSame topicHepatitis B Virus StudiesFrench-language works237,207